-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QkoxOwGF2XflfB9N3xHbrEsfsIfZgDPYt0Py/p4jYK3dVIA6rhIs5tqWeq+fIIvR bSoC72nPUjtqZp6jL38TOg== 0001104659-08-072420.txt : 20081121 0001104659-08-072420.hdr.sgml : 20081121 20081121155455 ACCESSION NUMBER: 0001104659-08-072420 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20081119 FILED AS OF DATE: 20081121 DATE AS OF CHANGE: 20081121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMATHENE, INC CENTRAL INDEX KEY: 0001326190 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202726770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 BUSINESS PHONE: 410 269 2600 MAIL ADDRESS: STREET 1: ONE PARK PLACE, SUITE 450 CITY: ANNAPOLIS STATE: MD ZIP: 21401 FORMER COMPANY: FORMER CONFORMED NAME: HEALTHCARE ACQUISITION CORP DATE OF NAME CHANGE: 20050505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WRIGHT DAVID P CENTRAL INDEX KEY: 0001206342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32587 FILM NUMBER: 081207536 BUSINESS ADDRESS: STREET 1: 6611 TRIBUTARY STREET STREET 2: C/O GUILFORD PHARMACEUTICALS INC CITY: BALTIMORE STATE: MD ZIP: 21224 BUSINESS PHONE: 4106316300 MAIL ADDRESS: STREET 1: C/O GUILFORD PHARMACEUTICALS INC STREET 2: 6611 TIBUTARY ST. CITY: BALTIMORE STATE: MD ZIP: 21224 4 1 a4.xml 4 X0303 4 2008-11-19 0 0001326190 PHARMATHENE, INC PIP 0001206342 WRIGHT DAVID P C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 1 1 0 1 President and CEO Member of Section 13(d) Group Common Stock 2008-11-19 4 P 0 45300 0.96 A 257115 D Common Stock 2008-11-20 4 P 0 50000 0.98 A 307115 D Exhibit List, Exhibit 24 - Confirming Statement /s/ Roland S. Chase, attorney in fact 2008-11-21 EX-24 2 ex-24.htm EX-24

Exhibit 24

CONFIRMING STATEMENT

This Statement confirms that the undersigned has authorized and designated Jordan P. Karp, Christopher C. Camut, Jeffrey A. Baumel and Roland S. Chase (the “Authorized Signatories”), or any one or more of them, to execute and file on the undersigned’s behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned’s ownership of or transactions in securities of PharmAthene, Inc. The authority of the Authorized Signatories under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to his/her ownership of, or transactions in, securities of PharmAthene, Inc., unless earlier revoked in writing. The undersigned acknowledges that Authorized Signatories are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

Dated:	November 20, 2008

Signed:	/s/ David P. Wright

Print Name:	David P. Wright

-----END PRIVACY-ENHANCED MESSAGE-----